---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-25-000114"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T11:18:43.737231+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions stockholders elect three Class I directors, ratify auditor, approve advisory compensation

## Summary
- Annual meeting held April 30, 2025; 36,140,808 shares (67% of outstanding) present.
- Class I directors Keith Katkin, Ronald Richard, Kathryn Zoon each elected with >18M votes for.
- Ernst & Young ratified as independent auditor for FY2025 with 34,773,959 for, 1,152,704 against.
- Advisory vote on named executive officer compensation approved with 18,928,777 for, 3,537,501 against.

## SEC filing metadata
- accession: 0001367644-25-000114
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/0001367644-25-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/ebs-20250430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-25-000114
- JSON: https://secwatch.observer/filing/0001367644-25-000114.json
- Plain text: https://secwatch.observer/filing/0001367644-25-000114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.